다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Virios Therapeutics Inc (VIRI)
Virios Therapeutics Inc (VIRI) 뉴스

VIRI

Virios Therapeutics (VIRI)

Virios Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:VIRI

1 2 3 4 5 6 7 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/10	23:30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:VIRI	Virios Therapeutics Inc
2024/05/09	21:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VIRI	Virios Therapeutics Inc
2024/05/09	20:45	GlobeNewswire Inc.	Virios Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update	NASDAQ:VIRI	Virios Therapeutics Inc
2024/05/08	06:25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VIRI	Virios Therapeutics Inc
2024/05/02	22:15	GlobeNewswire Inc.	Virios Therapeutics to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024	NASDAQ:VIRI	Virios Therapeutics Inc
2024/03/26	22:15	GlobeNewswire Inc.	Virios Therapeutics Announces Publication of International Patent for IMC-2 Covering Antiviral Treatment of Long-COVID	NASDAQ:VIRI	Virios Therapeutics Inc
2024/03/09	07:00	Edgar (US Regulatory)	Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]	NASDAQ:VIRI	Virios Therapeutics Inc
2024/03/07	06:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VIRI	Virios Therapeutics Inc
2024/03/01	23:10	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:VIRI	Virios Therapeutics Inc
2024/02/29	23:25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VIRI	Virios Therapeutics Inc
2024/02/29	23:15	GlobeNewswire Inc.	Virios Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:VIRI	Virios Therapeutics Inc
2024/02/29	03:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VIRI	Virios Therapeutics Inc
2024/02/29	03:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VIRI	Virios Therapeutics Inc
2024/02/29	02:56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VIRI	Virios Therapeutics Inc
2024/02/29	02:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VIRI	Virios Therapeutics Inc
2024/02/29	02:51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VIRI	Virios Therapeutics Inc
2024/02/29	02:47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VIRI	Virios Therapeutics Inc
2024/02/29	02:43	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VIRI	Virios Therapeutics Inc
2024/02/29	02:40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VIRI	Virios Therapeutics Inc
2024/02/28	23:15	GlobeNewswire Inc.	Virios Therapeutics Issues Shareholder Letter Highlighting Corporate Progress and Key Upcoming Milestones	NASDAQ:VIRI	Virios Therapeutics Inc
2024/02/28	06:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VIRI	Virios Therapeutics Inc
2024/02/03	06:31	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:VIRI	Virios Therapeutics Inc
2024/01/22	23:33	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:VIRI	Virios Therapeutics Inc
2024/01/22	23:00	GlobeNewswire Inc.	Virios Therapeutics Announces Plans to Advance Development of IMC-2 as Treatment for Symptoms Associated with Long-COVID	NASDAQ:VIRI	Virios Therapeutics Inc
2024/01/03	21:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VIRI	Virios Therapeutics Inc
2024/01/02	21:05	GlobeNewswire Inc.	Virios Therapeutics, Inc. Reaches Alignment with FDA on Requirements for Advancing Development Candidate IMC-2 as Treatment for Long-COVID	NASDAQ:VIRI	Virios Therapeutics Inc
2023/11/13	23:10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:VIRI	Virios Therapeutics Inc
2023/11/13	21:20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VIRI	Virios Therapeutics Inc
2023/11/13	21:05	GlobeNewswire Inc.	Virios Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update	NASDAQ:VIRI	Virios Therapeutics Inc
2023/11/07	21:29	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VIRI	Virios Therapeutics Inc

검색 관련기사 보기:NASDAQ:VIRI

1 2 3 4 5 6 7 다음 >>

Invesco QQQ Trust Series 1

Health Care Select Sector

Gold vs US Dollar

Verizon Communications

JP Morgan Chase

American Express

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관